Abstract

P2.17-05 Characterizing Mechanisms of Treatment Resistance in SCLC

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P2-04-02: Identifying molecular targets and mechanisms of treatment resistance in inflammatory breast cancer (IBC) using reverse-phase protein microarrays (RPMA)
Laura Austin ... Ron Hencin
American Journal of Cancer | VOL. 75
Laura Austin, et. al.Laura Austin ... Ron Hencin
30 Apr 2015
Abstract 4847: Identifying molecular targets and mechanisms of treatment resistance in inflammatory breast cancer (IBC) using next-generation sequencing (NGS) and reverse-phase protein microarrays (RPMA)
Laura K Austin ... Rebecca Jaslow
American Journal of Cancer | VOL. 75
Laura K Austin, et. al.Laura K Austin ... Rebecca Jaslow
01 Aug 2015
Squamous cell carcinoma differentiation at progression as a resistance mechanism in metastatic non-small cell lung carcinoma harbouring a targetable mutation
S Heynemann ... W.A Cooper
Pathology | VOL. 54
S Heynemann, et. al.S Heynemann ... W.A Cooper
12 May 2022
Role of SPTSSB-Regulated de Novo Sphingolipid Synthesis in Prostate Cancer Depends on Androgen Receptor Signaling.
Pedro Costa-Pinheiro ... Michael H Raymond
iScience | VOL. 23
Pedro Costa-Pinheiro, et. al.Pedro Costa-Pinheiro ... Michael H Raymond
23 Nov 2020
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
PP01.99 Switching to Subcutaneous (SC) Atezolizumab After Intravenous (IV) Dosing: Evaluation of Atezolizumab Pharmacokinetics (PK) Using Population PK Modeling
Stephanie N Liu ... Benjamin Wu
Journal of Thoracic Oncology | VOL. 19
Stephanie N Liu, et. al.Stephanie N Liu ... Benjamin Wu
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
View more papers